3. Chinenov Y, Rogatsky I (2007) Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network. Mol Cell Endocrinol 275: 30–42. 4. Luecke HF, Yamamoto KR (2005) The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev 19: 1116–1127. 5. Rogatsky I, Zarember KA, Yamamoto KR (2001) Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. Embo J 20: 6071–6083. 6. Clark AR (2007) Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endocrinol 275: 79–97. 7. Owens DM, Keyse SM (2007) Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26: 3203–3213. 8. Lang R, Hammer M, Mages J (2006) DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 177: 7497–7504. 9. Kaminska B (2005) MAPK signalling pathways as molecular targets for anti- inflammatory therapy–from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754: 253–262. 10. Dong C, Davis RJ, Flavell RA (2002) MAP kinases in the immune response. Annu Rev Immunol 20: 55–72. 11. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, et al. (2006) Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 26: 2399–2407. 12. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, et al. (2006) Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal- regulated kinase pathways. Mol Cell Biol 26: 2408–2418. 13. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, et al. (2006) Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 176: 1899–1907. 14. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, et al. (2006) MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 203: 131–140. 15. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, et al. (2006) Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 203: 1883–1889. 16. Barnes PJ (2006) Corticosteroid effects on cell signalling. Eur Respir J 27: 413–426. 17. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ (2007) Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109: 4313–4319. 18. Furst R, Schroeder T, Eilken HM, Bubik MF, Kiemer AK, et al. (2007) MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. Faseb J 21: 74–80. 19. Abraham SM, Clark AR (2006) Dual-specificity phosphatase 1: a critical regulator of innate immune responses. Biochem Soc Trans 34: 1018–1023. 20. Yamamoto KR (1985) Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 19: 209–252. 21. Lucas PC, Granner DK (1992) Hormone response domains in gene transcription. Annu Rev Biochem 61: 1131–1173. 22. Miner JN, Yamamoto KR (1991) Regulatory crosstalk at composite response elements. Trends Biochem Sci 16: 423–426. 23. Wang J-C, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq C, et al. (2004) Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocor- ticoid receptor target genes. Proceedings of the National Academy of Sciences of the United States of America 101: 15603–15608. 24. Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, et al. (2007) Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev 21: 2005–2017. 25. Wang JC, Shah N, Pantoja C, Meijsing SH, Ho JD, et al. (2006) Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity. Genes Dev 20: 689–699. 26. Kim JH, Yang CK, Stallcup MR (2006) Downstream signaling mechanism of the C-terminal activation domain of transcriptional coactivator CoCoA. Nucleic Acids Res 34: 2736–2750. 27. Koliwad SK, Kuo T, Shipp LE, Gray NE, Backhed F, et al. (2009) Angiopoietin- like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metab- olism. J Biol Chem 284: 25593–25601. Glucocorticoid-Induced DUSP1 28. Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA (2004) Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression. Mol Cell Biol 24: 4743–4756. 29. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, et al. (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352: 497–505. 30. Shahbazian MD, Grunstein M (2007) Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76: 75–100. 31. Tchen CR, Martins JR, Paktiawal N, Perelli R, Saklatvala J, et al. Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence. J Biol Chem 285: 2642–2652. 32. So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR (2007) Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3: e94. 33. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, et al. (2009) Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 19: 2163–2171. 34. Imai E, Stromstedt PE, Quinn PG, Carlstedt-Duke J, Gustafsson JA, et al. (1990) Characterization of a complex glucocorticoid response unit in the phospho- enolpyruvate carboxykinase gene. Mol Cell Biol 10: 4712–4719. 35. Scott DK, Mitchell JA, Granner DK (1996) The orphan receptor COUP-TF binds to a third glucocorticoid accessory factor element within the phospho- enolpyruvate carboxykinase gene promoter. J Biol Chem 271: 31909–31914. 36. Wang JC, Stromstedt PE, Sugiyama T, Granner DK (1999) The phosphoenol- pyruvate carboxykinase gene glucocorticoid response unit: identification of the functional domains of accessory factors HNF3 beta (hepatic nuclear factor-3 beta) and HNF4 and the necessity of proper alignment of their cognate binding sites. Mol Endocrinol 13: 604–618. 37. Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268: 5353–5356. 38. Espinas ML, Roux J, Ghysdael J, Pictet R, Grange T (1994) Participation of Ets transcription factors in the glucocorticoid response of the rat tyrosine aminotransferase gene. Mol Cell Biol 14: 4116–4125. 39. Roux J, Pictet R, Grange T (1995) Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene. DNA Cell Biol 14: 385–396. 40. Vander Kooi BT, Onuma H, Oeser JK, Svitek CA, Allen SR, et al. (2005) The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements. Mol Endocrinol 19: 3001–3022. 41. Johansson-Haque K, Palanichamy E, Okret S (2008) Stimulation of MAPK- phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP. J Mol Endocrinol 41: 239–249. 42. Nishio Y, Isshiki H, Kishimoto T, Akira S (1993) A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein- protein interaction. Mol Cell Biol 13: 1854–1862. 43. Alam T, An MR, Mifflin RC, Hsieh CC, Ge X, et al. (1993) trans-activation of the alpha 1-acid glycoprotein gene acute phase responsive element by multiple isoforms of C/EBP and glucocorticoid receptor. J Biol Chem 268: 15681–15688. 44. Yamada K, Duong DT, Scott DK, Wang JC, Granner DK (1999) CCAAT/ enhancer-binding protein beta is an accessory factor for the glucocorticoid response from the cAMP response element in the rat phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 274: 5880–5887. 45. Wyszomierski SL, Rosen JM (2001) Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/ enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol Endocrinol 15: 228–240. 46. Trotter KW, Archer TK (2007) Nuclear receptors and chromatin remodeling machinery. Mol Cell Endocrinol 265-266: 162–167. 47. John S, Sabo PJ, Johnson TA, Sung MH, Biddie SC, et al. (2008) Interaction of the glucocorticoid receptor with the chromatin landscape. Mol Cell 29: 611–624. 48. Sankar N, Baluchamy S, Kadeppagari RK, Singhal G, Weitzman S, et al. (2008) p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene 27: 5717–5728. 49. Girdwood D, Bumpass D, Vaughan OA, Thain A, Anderson LA, et al. (2003) P300 transcriptional repression is mediated by SUMO modification. Mol Cell 11: 1043–1054. PLoS ONE | www.plosone.org 11 October 2010 | Volume 5 | Issue 10 | e13754